In addition to the most common treatments for asthma, there are other means of controlling the symptoms that are not the regular, conventional means. Many asthma patients rely on unconventional treatment means as to not have to endure any possible side…
GSK starts Relovair phase-III asthma programme
GlaxoSmithKline (GSK) announced that the first asthma patient has commenced treatment with Relovair (fluticasone furoate/vilanterol trifenatate) in an asthma exacerbation study, marking the start of the phase-III clinical development programme with this once daily therapy, for…
Asthma is constant disease that affects the airways or the tubes that brings air in and out of the lungs. Asthmatics have inflamed airways or the inside walls of the airways are swollen with too much mucus creation making breathing…